Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 4 (KRT18P4) is one of numerous non-coding DNA sequences in the human genome that arose from duplication or retrotransposition of the protein-coding keratin 18 (KRT18) gene. It closely resembles KRT18 in sequence but does not encode a functional protein due to disabling mutations and/or lack of necessary regulatory elements. Unlike the functional keratin 18 gene, which plays essential roles in epithelial cell structure and is a clinically significant biomarker in oncology, KRT18P4 does not have any known physiological, pathological, or pharmacological relevance. The overwhelming majority of keratin gene pseudogenes, such as KRT18P4, are considered nonfunctional; their presence mainly reflects the evolutionary history of the keratin gene family.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 4 (KRT18P4).